Quantitative Analysis of Postural Instability in Patients with Parkinson’s Disease
Table 1
Participant demographics.
Group (N = 55)
H&Y I (N = 9)
H&Y II (N = 12)
H&Y III (N = 14)
H&Y IV (N = 8)
HC (N = 12)
Age (years)
59.67 ± 7.02
61.50 ± 8.37
65.21 ± 7.50
63.25 ± 8.96
62.90 ± 7.39
Gender (% female)
8.11
24.32
27.03
10.81
13.51
Weight (kg)
79.33 ± 10.07
71.07 ± 8.38
72.17 ± 12.28
70.43 ± 15.45
77.00 ± 11.38
Height (cm)
171.00 ± 3.61
168.93 ± 5.18
165.92 ± 6.40
166.14 ± 8.28
170.30 ± 5.79
MDS-UPDRS (III)
22.33 ± 1.80
33.75 ± 7.21
39.86 ± 1201
46.50 ± 11.33
R
3.33 ± 1.00
5.50 ± 2.28
5.57 ± 2.21
6.75 ± 3.06
B
10.00 ± 2.00
14.14 ± 2.88
16.38 ± 5.19
18.71 ± 7.06
A
6.33 ± 2.18
8.33 ± 2.74
11.50 ± 1.09
13.75 ± 5.97
T
4.00 ± 4.58
4.67 ± 3.34
11.36 ± 3.89
11.88 ± 1.13
LEDD (mg)
166.67 ± 115.47
355.36 ± 142.16
447.88 ± 123.97
573.40 ± 162.65
Disease duration (years)
1.67 ± 0.58
3.86 ± 2.14
5.85 ± 2.15
6.29 ± 1.38
Data are presented as the mean ± standard deviation or proportion. H&Y= Hoehn and Yahr stage, HC = healthy control, MDS-UPDRS = Movement Disorder Society Revised Unified Parkinson’s Disease Rating Scale, R = rigidity subscore, B = bradykinesia subscore, A = axial subscore, T = tremor subscore, LEDD = levodopa equivalent daily dose.
